Administration of conophylline and betacellulin-δ4 increases the β-cell mass in neonatal streptozotocin-treated rats

Tsutomu Kodera, Satoko Yamada, Yoritsuna Yamamoto, Akemi Hara, Yuji Tanaka, Masaharu Seno, Kazuo Umezawa, Izumi Takei, Itaru Kojima

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The present study was conducted to examine the effect of administration of conophylline (CnP) and betacellulinδ4 (BTCδ4) on the β-cell mass in neonatal streptozotocin-treated rats (neonatal STz rats). STz (100 μg/g) was injected into neonatal rats, and then CnP (2 μg/g) and/or BTCδ4 (200 pmol/g) were administered to neonatal STZ rats for 1 week. The plasma glucose concentration was monitored, and an intraperitoneal glucose tolerance test (ipGTT) was performed on day 8 and at 8 weeks after the STZ injection. In neonatal STZ rats treated with control solution (S group), the plasma glucose concentration increased for several days after the STZ injection, returned to nearly normal levels, and then increased gradually after six weeks of age. Eight weeks after the STZ-injection, the plasma glucose concentration was increased significantly compared to that of normal rats. The glucose response to ipGTT was significantly reduced in neonatal STZ rats treated with CnP (CnP group), BTCδ4 (δ4 group) and CnP+BTCδ4 (CnP+δ4 group). The β-cell mass and the insulin content of the pancreas were significantly increased in the CnP group and δ4 group. The effect of CnP+δ4 was greater than that of CnP alone or BTCδ4 alone. CnP+BTCδ4 significantly increased the number of PDX-1-positive ductal cells and the number of insulin/BrdU double-positive ductal cells. These results indicate the efficacy of CnP and BTCδ4 in increasing the β-cells mass of neonatal STZ-treated rats.

Original languageEnglish
Pages (from-to)799-806
Number of pages8
JournalEndocrine Journal
Volume56
Issue number6
DOIs
Publication statusPublished - 2009

Fingerprint

Streptozocin
Glucose
Glucose Tolerance Test
Injections
Betacellulin
conophylline
Insulin
Bromodeoxyuridine
Pancreas
Cell Count

Keywords

  • Differentiation
  • Insulin
  • Neogenesis
  • Regeneration

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Administration of conophylline and betacellulin-δ4 increases the β-cell mass in neonatal streptozotocin-treated rats. / Kodera, Tsutomu; Yamada, Satoko; Yamamoto, Yoritsuna; Hara, Akemi; Tanaka, Yuji; Seno, Masaharu; Umezawa, Kazuo; Takei, Izumi; Kojima, Itaru.

In: Endocrine Journal, Vol. 56, No. 6, 2009, p. 799-806.

Research output: Contribution to journalArticle

Kodera, T, Yamada, S, Yamamoto, Y, Hara, A, Tanaka, Y, Seno, M, Umezawa, K, Takei, I & Kojima, I 2009, 'Administration of conophylline and betacellulin-δ4 increases the β-cell mass in neonatal streptozotocin-treated rats', Endocrine Journal, vol. 56, no. 6, pp. 799-806. https://doi.org/10.1507/endocrj.K09E-158
Kodera, Tsutomu ; Yamada, Satoko ; Yamamoto, Yoritsuna ; Hara, Akemi ; Tanaka, Yuji ; Seno, Masaharu ; Umezawa, Kazuo ; Takei, Izumi ; Kojima, Itaru. / Administration of conophylline and betacellulin-δ4 increases the β-cell mass in neonatal streptozotocin-treated rats. In: Endocrine Journal. 2009 ; Vol. 56, No. 6. pp. 799-806.
@article{1931eeb768d2474293b3dbe99ddafbc0,
title = "Administration of conophylline and betacellulin-δ4 increases the β-cell mass in neonatal streptozotocin-treated rats",
abstract = "The present study was conducted to examine the effect of administration of conophylline (CnP) and betacellulinδ4 (BTCδ4) on the β-cell mass in neonatal streptozotocin-treated rats (neonatal STz rats). STz (100 μg/g) was injected into neonatal rats, and then CnP (2 μg/g) and/or BTCδ4 (200 pmol/g) were administered to neonatal STZ rats for 1 week. The plasma glucose concentration was monitored, and an intraperitoneal glucose tolerance test (ipGTT) was performed on day 8 and at 8 weeks after the STZ injection. In neonatal STZ rats treated with control solution (S group), the plasma glucose concentration increased for several days after the STZ injection, returned to nearly normal levels, and then increased gradually after six weeks of age. Eight weeks after the STZ-injection, the plasma glucose concentration was increased significantly compared to that of normal rats. The glucose response to ipGTT was significantly reduced in neonatal STZ rats treated with CnP (CnP group), BTCδ4 (δ4 group) and CnP+BTCδ4 (CnP+δ4 group). The β-cell mass and the insulin content of the pancreas were significantly increased in the CnP group and δ4 group. The effect of CnP+δ4 was greater than that of CnP alone or BTCδ4 alone. CnP+BTCδ4 significantly increased the number of PDX-1-positive ductal cells and the number of insulin/BrdU double-positive ductal cells. These results indicate the efficacy of CnP and BTCδ4 in increasing the β-cells mass of neonatal STZ-treated rats.",
keywords = "Differentiation, Insulin, Neogenesis, Regeneration",
author = "Tsutomu Kodera and Satoko Yamada and Yoritsuna Yamamoto and Akemi Hara and Yuji Tanaka and Masaharu Seno and Kazuo Umezawa and Izumi Takei and Itaru Kojima",
year = "2009",
doi = "10.1507/endocrj.K09E-158",
language = "English",
volume = "56",
pages = "799--806",
journal = "Endocrine Journal",
issn = "0918-8959",
publisher = "Japan Endocrine Society",
number = "6",

}

TY - JOUR

T1 - Administration of conophylline and betacellulin-δ4 increases the β-cell mass in neonatal streptozotocin-treated rats

AU - Kodera, Tsutomu

AU - Yamada, Satoko

AU - Yamamoto, Yoritsuna

AU - Hara, Akemi

AU - Tanaka, Yuji

AU - Seno, Masaharu

AU - Umezawa, Kazuo

AU - Takei, Izumi

AU - Kojima, Itaru

PY - 2009

Y1 - 2009

N2 - The present study was conducted to examine the effect of administration of conophylline (CnP) and betacellulinδ4 (BTCδ4) on the β-cell mass in neonatal streptozotocin-treated rats (neonatal STz rats). STz (100 μg/g) was injected into neonatal rats, and then CnP (2 μg/g) and/or BTCδ4 (200 pmol/g) were administered to neonatal STZ rats for 1 week. The plasma glucose concentration was monitored, and an intraperitoneal glucose tolerance test (ipGTT) was performed on day 8 and at 8 weeks after the STZ injection. In neonatal STZ rats treated with control solution (S group), the plasma glucose concentration increased for several days after the STZ injection, returned to nearly normal levels, and then increased gradually after six weeks of age. Eight weeks after the STZ-injection, the plasma glucose concentration was increased significantly compared to that of normal rats. The glucose response to ipGTT was significantly reduced in neonatal STZ rats treated with CnP (CnP group), BTCδ4 (δ4 group) and CnP+BTCδ4 (CnP+δ4 group). The β-cell mass and the insulin content of the pancreas were significantly increased in the CnP group and δ4 group. The effect of CnP+δ4 was greater than that of CnP alone or BTCδ4 alone. CnP+BTCδ4 significantly increased the number of PDX-1-positive ductal cells and the number of insulin/BrdU double-positive ductal cells. These results indicate the efficacy of CnP and BTCδ4 in increasing the β-cells mass of neonatal STZ-treated rats.

AB - The present study was conducted to examine the effect of administration of conophylline (CnP) and betacellulinδ4 (BTCδ4) on the β-cell mass in neonatal streptozotocin-treated rats (neonatal STz rats). STz (100 μg/g) was injected into neonatal rats, and then CnP (2 μg/g) and/or BTCδ4 (200 pmol/g) were administered to neonatal STZ rats for 1 week. The plasma glucose concentration was monitored, and an intraperitoneal glucose tolerance test (ipGTT) was performed on day 8 and at 8 weeks after the STZ injection. In neonatal STZ rats treated with control solution (S group), the plasma glucose concentration increased for several days after the STZ injection, returned to nearly normal levels, and then increased gradually after six weeks of age. Eight weeks after the STZ-injection, the plasma glucose concentration was increased significantly compared to that of normal rats. The glucose response to ipGTT was significantly reduced in neonatal STZ rats treated with CnP (CnP group), BTCδ4 (δ4 group) and CnP+BTCδ4 (CnP+δ4 group). The β-cell mass and the insulin content of the pancreas were significantly increased in the CnP group and δ4 group. The effect of CnP+δ4 was greater than that of CnP alone or BTCδ4 alone. CnP+BTCδ4 significantly increased the number of PDX-1-positive ductal cells and the number of insulin/BrdU double-positive ductal cells. These results indicate the efficacy of CnP and BTCδ4 in increasing the β-cells mass of neonatal STZ-treated rats.

KW - Differentiation

KW - Insulin

KW - Neogenesis

KW - Regeneration

UR - http://www.scopus.com/inward/record.url?scp=70349967847&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349967847&partnerID=8YFLogxK

U2 - 10.1507/endocrj.K09E-158

DO - 10.1507/endocrj.K09E-158

M3 - Article

C2 - 19550075

AN - SCOPUS:70349967847

VL - 56

SP - 799

EP - 806

JO - Endocrine Journal

JF - Endocrine Journal

SN - 0918-8959

IS - 6

ER -